Press release
SideEffectActos.com: New Webstie Launched to Handle Actos Bladder Cancer Claims
Los Angeles, CA, November 25, 2011 – National law firm Nadrich & Cohen, LLP has established a new website to reach out to Actos users who have developed bladder cancer. The new site, http://www.SideEffectActos.com, offers Actos users information about bladder cancer symptoms, a complete history of FDA warnings regarding the drug and the latest news about the Actos lawsuits.The California-based law firm is currently investigating claims from Actos users in all 50 states who allege that they developed bladder cancer after using the drug. Actos was first approved in 1999 to treat patients with Type 2 diabetes. The link between Actos and bladder cancer was first established in 2010, after research showed that patients who used the drug had a significantly higher risk of developing cancer.
In June of this year, health officials in France and Germany pulled Actos off the market, citing health and safety concerns. At the time of publication, the European Medical Agency was still supporting the use of Actos for Type 2 diabetes patients if other treatments prove ineffective.
While the U.S. Food and Drug Administration has yet to issue a similar recall, numerous health warnings have been issued, advising Actos users of the increased bladder cancer risk. Multiple lawsuits have since been filed against Japan’s Takeda Pharmaceuticals, the maker of the drug. The lawsuits allege that Takeda knew of the potential side effects of Actos but did nothing to warn consumers of the risk.
Nadrich & Cohen, LLP created http://www.SideEffectActos.com in an effort to connect with Actos users who may have experienced adverse side effects from taking the drug. Visitors to the site can use an online contact form to submit their information to member of Nadrich & Cohen’s Actos legal team. The firm is currently offer free case evaluations to all potential claimants.
If you’ve experienced bladder cancer symptoms after taking Actos, you need to contact an experienced Actos attorney immediately to discuss your case. You may have grounds for a personal injury lawsuit but each state limits the time frame differently for filing claims. Visit http://www.SideEffectActos.com to get more information on the link between Actos and bladder cancer or to connect with an Actos bladder cancer injury lawyer.
###
Contact:
Nadrich & Cohen, LLP
12100 Wilshire Blvd Suite 1250
Los Angeles, CA 90025
(800) 722-0765
http://www.personalinjurylawcal.com
Nadrich & Cohen, LLP is a national law firm specializing in personal injury cases. We assist individuals in all 50 states in filing claims for injuries stemming from defective medical devices, harmful prescription drugs, car accidents, motorcycle accidents, bicycle accidents and dog bites.
12100 Wilshire Blvd. Suite 1250
Los Angeles, CA 90025
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SideEffectActos.com: New Webstie Launched to Handle Actos Bladder Cancer Claims here
News-ID: 202172 • Views: …
More Releases from Nadrich & Cohen, LLP
Johnson & Johnson Defends Withdrawal of PMA for Rejected Hips
Nadrich & Cohen, LLP reports that Johnson & Johnson is defending its withdrawal of a PMA for a rejected metal hip device that was reportedly sold overseas.
Los Angeles, CA, February 16, 2012 – The Johnson & Johnson Company is facing more criticism after a recent New York Times article revealed that the company continued to market a metal hip resurfacing system overseas, despite the fact that the FDA failed to…
Actos Bladder Cancer Lawsuits Continue to Mount as Attorneys Push for Consolidat …
With new Actos bladder cancer lawsuits being filed every day, the plaintiffs and their attorneys are urging for the consolidation of these cases. Some 3500 Actos lawsuits have been filed in state and federal courts across the country, including Illinois, New York, New Jersey, Ohio and California. The law firm of Nadrich & Cohen LLP is currently investigating claims from Actos users in all 50 states who claim they developed…
New Actos Bladder Cancer Resource Center Offers Answers to Concerned Patients
Los Angeles, CA, December 6, 2011 -- Nadrich & Cohen LLP, a prominent national law firm, has established a new website geared towards helping Actos users who developed bladder cancer after taking the drug. Visitors to the new site, www.SideEffectActos.com, can find the latest updates, news and information on the Actos bladder cancer litigation.
The link between Actos and bladder cancer first came to light in September 2010, when the…
New Vaginal Mesh Safety Recommendations Issued
National law firm Nadrich & Cohen LLP is endorsing new recommendations issued by the American College of Obstetricians and Gynecologists (ACOG) and the American Urogynecologic Society (AUGS) regarding the use of transvaginal mesh to treat pelvic organ prolapse in certain women.
In a joint statement, the two organizations called for physicians to limit their use of vaginal mesh only to high-risk women for whom other treatment methods would not be…
More Releases for Actos
Initial Hearing Scheduled in Federal Actos Bladder Cancer Litigation
Nadrich & Cohen, LLP reports that the federal judge presiding over the consolidated Actos bladder cancer cases has scheduled the first hearing in the pending litigation.
Los Angeles, CA, February 14, 2012 – Judge Rebecca Doherty issued an order on Monday announcing that she would be appointing lead counsel for the consolidated Actos lawsuits following a March 22nd status conference set to take place in Lafayette, LA. Judge Doherty was assigned…
Federal Panel Votes to Consolidate Actos Bladder Cancer Lawsuits
Nadrich & Cohen LLP reports that a federal judicial panel has voted to consolidate pending Actos bladder cancer claims into a multidistrict litigation for pretrial proceedings.
Los Angeles, CA, January 5, 2012 – Plaintiffs in the Actos bladder cancer litigation have successfully moved to have the federal lawsuits consolidated into a multidistrict litigation for pretrial proceedings. The cases will be transferred to the Western District Court of Louisiana, with the…
More Actos Bladder Cancer Lawsuits Filed in Los Angeles
Nadrich & Cohen LLP reports that new lawsuits have been filed in Los Angeles against the maker of Actos by two patients who allege the drug caused bladder cancer.
Los Angeles, CA, December 30, 2011 – As Takeda Pharmaceuticals continues to battle litigation over its Type 2 diabetes drug Actos, three additional lawsuits were filed in a Los Angeles court. The newest claims join the thousands of other Actos lawsuits that…
Takeda Pharmaceuticals, Eli Lilly Face Actos Class Action Lawsuit in Canada
Los Angeles, CA, December 22, 2011 – A class action lawsuit was filed in an Ontario Superior Court against Japanese drug-maker Takeda Pharmaceuticals, alleging that the company knew its popular Type 2 diabetes drug Actos causes bladder cancer. The class action suit also names Eli Lilly as a defendant.
According to court records, the lead plaintiff in the action is a Toronto woman who began taking Actos in 2002. The…
Despite Bladder Cancer Lawsuits, Generic Actos May Hit Market Next Year
Takeda Pharmaceuticals, the manufacturer of Type 2 diabetes drug Actos, may face stiff competition from generic competitors when the drug’s patent expires in August 2012. The Japanese drug-maker also faces trouble on another front in the form of thousands of lawsuits filed by Actos users who allege the drug caused them to develop bladder cancer.
Takeda has previously settled lawsuits from a number of drug manufacturers which would allow the…
Nadrich & Cohen Now Reviewing Actos Bladder Cancer Claims
Los Angeles, CA, December 12, 2011 – Nadrich & Cohen LLP, a prominent national law firm, is now reviewing claims from Actos users in all 50 states who developed bladder cancer after taking the drug. In an effort to connect with even more Actos users across the country, the firm has established an online resource center at www.SideEffectActos.com.
Actos was approved by the U.S. Food and Drug Administration to treat adults…
